Tamoxifen is a selective estrogen receptor modulator used in the adjuvant treatment of hormone receptor positive (HR+), i.e., estrogen receptor and/or progesterone receptor positive breast cancer. The gene discussed is ESR1; the disease is breast carcinoma.